Key result
Dihydroergotamine increases systemic and central venous pressure, vascular resistance, and orthostatic tolerance in postural hypotension.
Why the study?
Does dihydroergotamine improve orthostatic tolerance and hemodynamics in patients with postural hypotension?
Does dihydroergotamine improve orthostatic tolerance and hemodynamics in patients with postural hypotension?
Dihydroergotamine improves orthostatic tolerance in patients with postural hypotension by constricting both capacitance and resistance vessels, particularly under conditions of low sympathetic tone.
Answers are grounded in this paper and cite their sources.
May support vasoconstrictor use in postural hypotension; Level 5 data leave efficacy unproven and practice unchanged.
In five patients with postural hypotension (disturbed sympathetic vasomotor control) the effect of intravenous and oral administration of dihydroergotamin (DHE) has been studied. The therapeutic effect of oral administration of DHE has also been compared to the effect of treatment with an antigravity suit. Following intravenous administration of DHE, systemic and central venous pressure increased in all cases. The effect on cardiac output was negligible and consequently the calculated total peripheral vascular resistance increased. Orthostatic tolerance increased in all cases. During long-term oral administration the effect was comparable to that obtained with an antigravity suit. The increased orthostatic tolerance is explained by a constrictive effect on both capacitance and resistance vessels. In order to analyze the influence of a functional denervation on the effect of DHE on peripheral circulation, a study has also been performed during epidural anaesthesia of the lower body in 11 patients. In the legs which were deprived of sympathetic tone intravenous administration of DHE caused constriction of resistance vessels. In the intact forearm there was a decrease of tone in the resistance vessels. The results indicate that DHE - apart from its well-known venoconstrictive effect - also may constrict resistance vessels when they are subjected to a low sympathetic nervous outflow.
No takes yet. Share an insight, caveat, or question.
rd et al. (2008) studied Postural hypotension (n=16). Dihydroergotamine (DHE) vs. Antigravity suit was evaluated on Circulatory effects including systemic and central venous pressure, cardiac output, and orthostatic tolerance. Dihydroergotamine administration increased systemic and central venous pressure, peripheral vascular resistance, and orthostatic tolerance in patients with postural hypotension.
Synapse has enriched 10 related papers. Consider them for comparative context: